Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Othera Pharmaceuticals logo — company profile

Othera Pharmaceuticals

Founded 2002 United States Exton, United States 27 employees Debt Financing Total: $23.62M Biotechnology, Health Care +1

General Information

Company Name Othera Pharmaceuticals
Founded Year 2002
Location United States Exton, United States
Employees 27
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Othera Pharmaceuticals. To contact Othera Pharmaceuticals, visit othera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Othera Pharmaceuticals

Othera Pharmaceuticals, founded in 2002, is a pharmaceutical company focused on advancing innovative therapeutics for age-related diseases of the eye. The company's flagship product, OT-551, is currently undergoing Phase II clinical trials for the dry form of macular degeneration (AMD). Notably, the company has revealed promising interim data from the trial and anticipates releasing full trial results by mid-2010. With headquarters in the United States, Othera is also dedicated to pioneering novel treatments for glaucoma and neurodegenerative diseases. As of 04 August 2009, the company secured a significant $10.62M debt financing investment, highlighting investor confidence in its pioneering approach to addressing critical unmet medical needs within the Biotechnology, Health Care, and Pharmaceutical industries.

Taxonomy: ophthalmic diseases, pharmaceutical company, dry AMD, biopharmaceuticals, drug development, clinical trials, neuroprotectant, glaucoma treatment, ophthalmology, OT-551, OT-730, OT-440

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $10.62M -
04 Aug 2009
Series B $13.00M 3
NewSpring Ventures Johnson & Johnson Development Corporation
NewSpring Ventures, Johnson & Johnson Development Corporation +1
19 Aug 2004

Othera Pharmaceuticals Alternatives & Competitors

Othera Pharmaceuticals vs
Kinarus Therapeutics
Kinarus Therapeutics Switzerland

Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respiratory and ocu...

Post-IPO Equity
5 employees
Biopharma, Biotechnology
Othera Pharmaceuticals vs
Beacon Therapeutics
Beacon Therapeutics United Kingdom

Transforming Vision, Transforming Lives

Series C
95 employees
Biotechnology, Health Care
Othera Pharmaceuticals vs
Acuity Pharmaceuticals
Acuity Pharmaceuticals

Advancing Ophthalmic Health with Pioneering Solutions

Series B
Health Care, Pharmaceutical
Also compare with: Othera Pharmaceuticals vs BBB Therapeutics BBB Therapeutics

FAQ About Othera Pharmaceuticals

Othera is a pharmaceutical company developing novel therapeutics for age-related diseases of the eye. Othera's lead compound, OT-551 is an eye drop in a Phase II clinical trial for the dry form of macular degeneration (AMD), and recently announced positive interim data from that trial, with full tri...
Othera Pharmaceuticals was founded in 2002.
Othera Pharmaceuticals is headquartered in Exton, United States.
Othera Pharmaceuticals operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on ophthalmic diseases, pharmaceutical company, dry AMD and biopharmaceuticals.
Othera Pharmaceuticals has approximately 27 employees.
Othera Pharmaceuticals has completed 2 funding rounds, raising a total of $23.62M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Othera Pharmaceuticals include Kinarus Therapeutics, Beacon Therapeutics, Acuity Pharmaceuticals, Alkeus Pharmaceuticals, Inc., Inflammx Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Othera Pharmaceuticals and Kinarus Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Othera Pharmaceuticals, https://bouncewatch.com/company/othera-pharmaceuticals, updated 28 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes